UPDATE: Oppenheimer Starts Horizon Therapeutics (HZNP) at Outperform
Tweet Send to a Friend
(Updated - March 14, 2022 4:03 PM EDT)
Oppenheimer analyst Leland Gershell initiates coverage on Horizon Therapeutics (NASDAQ: HZNP) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Leland Gershell initiates coverage on Horizon Therapeutics (NASDAQ: HZNP) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
